A breast cancer research study now open at Baylor University Medical Center in Dallas is believed to be the first of its kind to explore the ability of new weight loss GIP/GLP-1 receptor agonists to combat breast cancer recurrence in overweight or obese pa
...
Several Baylor Scott & White clinicians were recently named to Clarivate’s 2024 list of “Highly Cited Researchers” for authoring some of the most widely cited scientific publications in their fields, ranking among the top 1% of their peers.
In 2023, Baylor Scott & White Quality Alliance, the largest clinically integrated network in Texas, significantly exceeded average performance for nearly all quality measures tracked by the Medicare Shared Savings Program (MSSP) and remains a top performer
...
The US Army Medical Research and Development Command, a division of the Department of Defense, awarded a $2.7 million grant to Dr. Ann Marie Warren, PhD, ABPP, principal investigator for Baylor Scott & White Research Institute, to research prevent Post-tra
...
In collaboration with Exact Sciences, Baylor Scott & White Research Institute are now enrolling its first patients in the Texas Multi-Cancer Early Detection (MCED) Registry.
Baylor University Medical Center’s uterus transplant program—the largest of its kind in the world—published the results of an eight-year trial in JAMA, finding the procedure is safe and effective, resulting in a high rate of live births. The seminal study
...
